Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Greenway Schond L.
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Karlin Dan
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Barrow Robert
Mind Medicine | SC 13G: Statement of acquisition of beneficial ownership by individuals-Commodore Capital LP(8.3%),Commodore Capital Master LP(8.3%)
Mind Medicine | D: Filing D
Mind Medicine | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.49%),Deep Track Biotechnology Master Fund, Ltd.(9.49%), etc.
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Mark
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Barrow Robert
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Liao Carrie
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Wernli Miri Halperin
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Karlin Dan
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Greenway Schond L.
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Karlin Dan
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Barrow Robert
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Greenway Schond L.
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Barrow Robert
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Karlin Dan
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Greenway Schond L.
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Greenway Schond L.
Mind Medicine | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Barrow Robert
No Data